Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Global $45 Bn Autoimmune Disease Treatment Market, 2022

Research and Markets
Posted on: 21 Sep 17

PR Newswire

DUBLIN, September 21, 2017

DUBLIN, September 21, 2017 /PRNewswire/ --

The "Global Autoimmune Disease Treatment Market - By Disease Type, Diagonostics, Products, Region - Market Size, Demand Forecasts, Industry Trends and Updates (2016-2022)" report has been added to Research and Markets' offering.

Global autoimmune diseases treatment market is estimated to grow at a CAGR of 3.80% for the forecasted period, and its market value is expected to reach $45.54 billion by 2022 from $36.41 billion in 2016

Autoimmune diseases occur when the immune system of an individual's body treats healthy cells of his/her very own body as foreign cells and attacks them. These diseases causes variations in organ functioning, abnormal growth of organs and destruction of healthy body tissues. Autoimmune diseases are mostly chronic in nature and there is no curative therapy., Dermatomyositis, Type 1 diabetes Hashimoto's disease, Sjogren's syndrome, Psoriasis are some of the examples of Autoimmune diseases. Systemic autoimmune diseases treatment and Localized autoimmune disease treatment are two types of autoimmune disease treatment.

Various types of treatments for these diseases include Physical therapy, blood transfusion, Recombinant technology, Chemo therapy, Topical therapy, TNF-a antagonists and Helminthic therapy. Women, generally, have higher incidences of these diseases compared to men.

Dominance of North America and Europe in autoimmune disease market can be attributed to factors like prevalence of autoimmune diseases, increasing investments in R&D and higher disposable income in these regions. Factors such as improving health infrastructure, increasing awareness among people about heath care and increasing aging populations are going to fuel the rapid growth of autoimmune disease treatment market in Asia-Pacific region in the next five years.

Availability of various biosimilar drugs, Government initiatives and support to restrict autoimmune diseases are also major factors contributing for the growth of this market. Lack of standardized treatment for these diseases, Poorly trained physicians, low medical insurance coverage and low levels of awareness among public about these diseases are some of the challenges for this industry.

This industry comprises price based intense competition among various players. Some of the major players operating in autoimmune disease treatment market include Abott Laboratories, Roche, Johnson&Johnson, Beckman Coulter Inc., Pfizer, Lupin Limited and GlaxoSmithKline plc.

Key Topics Covered:

1. Research Methodology

2. Executive Summary

3. Market Overview

  • Definition
  • Value Chain Analysis
  • Porter's 5 Forces
  • Regulations

4. Market Dynamics

  • Introduction
  • Drivers
  • Constraints
  • Opportunities

5. Global Autoimmune Disease Treatment Market Segmentation, Forecasts and Trends - By Revenue

6. By Disease type

  • Localized
  • Systemic

7. By Diagonostics

  • IFA
  • ELISA
  • Dot blot
  • Line blot
  • Aggultination
  • Double immune diffusion
  • Western Blotting
  • Multiplex immunoassay
  • Others

8. By Products

  • Drugs
  • Therapeutic and monitoring equipment
  • Diagonostic equipments

9. By Region

  • North America
  • U.S.
  • Canada
  • Europe
  • U.K.
  • Germany
  • France
  • Italy
  • Spain
  • Russia
  • Switzerland
  • Others
  • Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Others
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Others
  • MEA
  • UAE
  • Saudi Arabia
  • South Africa
  • Others

10. Vendor Market Share Analysis

11. Company Profiles

  • Abbott Laboratories
  • Active Biotech
  • Eli Lilly
  • Bristol-Myers Squibb
  • AstraZeneca plc
  • Pfizer
  • Biogen Idec
  • Lupin Limited
  • GlaxoSmithKline
  • Amgen
  • 4SC AG
  • F. Hoffmann-La Roche Ltd.
  • AutoImmune Inc
  • Johnson & Johnson
  • Bayer
  • Others

12. Industry Structure

  • Industry M&As, Consolidations
  • Investment Opportunities

13. Global Autoimmune Disease Treatment market - Road Ahead

  • Tables
  • Disclaimer

For more information about this report visit https://www.researchandmarkets.com/research/389pn9/global_autoimmune

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

View original content:http://www.prnewswire.com/news-releases/global-45-bn-autoimmune-disease-treatment-market-2022-300523885.html

SOURCE Research and Markets

PR Newswire
www.prnewswire.com

Last updated on: 21/09/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.